INVESTOR DEADLINE: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
cept Therapeutics rporated(US:CORT) Businesswire·2026-02-25 01:05公司法律诉讼事件 - 一项针对公司的诉讼指控称，被告未能披露美国食品药品监督管理局对支持瑞拉考利兰新药上市申请的证据充分性提出了担忧 [1]